Search PubMed⌕ Search

Biomedical subjects

P Ghezzi

Publications and source records attributed to P Ghezzi.

At least 181 records · Page 10Linked to original sources

Effect of oral monosodium glutamate on glutamic acid levels in the nucleus arcuatus of the hypothalamus and on serum osmolality of adult and infant mice.

Monosodium glutamate (MSG) given by gavage to 7-day-old mice at 2 g/kg body weight (b.wt.) as a 20% solution w/v resulted in a 27% increase in the glutamic acid (GA) content in the nucleus arcuatus of the hypothalamus (NAH). When MSG was administered by gavage to adult mice at 4 g/kg b.wt. as a 20% solution w/v, GA levels in NAH remained unchanged. Serum osmolality, measured after oral MSG, was elevated in infant mice but was unaffected in adults.

Animals↗

Plasma glutamic acid levels in premature newborn.

24 premature, newborn infants were investigated for plasma glutamic acid (GA) levels before and after a normal milk feed, to ascertain if the ingestion of GA present in the milk could result in an increase of its plasma level. No increases were detected in plasma between 5 and 90 min after the feed. These results may be important in respect to the problem of the possible toxicity of monosodium glutamate (MSG) added to baby foods.

Animals↗

[Conductivity of the dialysis bath. Measurement, significance and electrolyte and clinical correlations].

The problem of the conductivity of dialysing solution is discussed. Measurement technique is analysed, highlighting the possibility of error connected with variations in the temperature of the dialysis bath, its mixture, the presence of air bubbles and the presence of dissolved substances that are not electrical charge carriers, and stressing the absolute proportionality with free ions and not with total ions. On the basis of these observations, the lack of any real, reliable correlation between conductivity and electrolytic composition of the dialysing solution unless particular conditions are respected is pointed out. Most important of these are exact knowledge of the composition of the mother solution and the degree of purity of the water. In conclusion, the imprecision of the values given by clinical and technological tradition and widely accepted is pointed out. Such values do not correspond to correct measurement.

Electric Conductivity↗

[Attempt to solve technical problems involved in the re-utilization of coil filters for hemodialysis].

The problem of the reutilization of coil filters in haemodialysis is discussed. The methodologies in current use are examined and the technical risks and inconveniences that limit any real economic advantage are pointed out. On the basis of these observations, a system of reutilization is proposed which does not call for any direct handling of the filter nor any special techniques for eliminating risks of transmitting infection, and cuts to the minimum extra work involving the use of hospital staff. The proposed equipment is illustrated in detail. It consists of a small accessory individual monitor which has opened the way to the concept of "weekly dialyser". Attention is called to the need for further research into the physiopathology of the regenerated membrane, particularly in relation to the type of filter, the number of reutilizations, and the behaviour of ultrafiltration and the various solutes.

Acute Kidney Injury↗

[Studies on the ultrafiltration in coil-type dialysers for recirculation].

Ultrafiltration in recirculating coil dialysers is discussed. The difficulty of determining the exact transmembrane pressure is stressed. The data normally available are insufficient and take no account of the direction of recirculation, which may be a determining factor. Input and output dialysing fluid pressure were measured in vitro and the respective ultrafiltration values were compared with those observed clinically. Calculation of the mean blood pressure in the dialyser circuit is examined. If determined from the simple arithmetical mean between the input and output pressure, this does not reflect the real situation inside the filter. It is thus unreliable when used to calculate the real transmembrane pressure, and hence the ultrafiltration.

Humans↗

[Acute hemodialysis with a single needle].

The problems of vascular access in acute haemodialysis are illustrated in brief. On the basis of the literature and personal experience, the usefulness of percutaneous cannulation of the femoral vein is maintained and its technical advantages, reasonable simplicity and practicability are recalled. Finally the use is proposed of a technique based on a new single needle capable of speedily resolving the problem of vascular access in acute patients.

Acute Kidney Injury↗

Weekly artificial kidney: personal monitor with cartridge re-use.

Cartridge re-use is now successful in centre and home haemodialysis. The economic advantage of re-use is remarkable even in the case of a single re-use. However, hepatitis and pyrogenic reactions may follow re-use and are a source of possible contamination. The problem of storing sterilised cartridges also arises. In order to reduce the work load and simplify preparation and re-use the authors have developed a simple 'personal monitor' that permits automatic recovery of the cartridge and eliminates handling. In our unit this 'personal monitor' has been used for 14 months without complications and with considerable saving. By using the same cartridge three times for each patient, the aim of a 'weekly kidney' has been achieved.

Humans↗

Mycobacterium tuberculosis heat shock protein 10 increases both proliferation and death in mouse P19 teratocarcinoma cells.

Exogenously added Mycobacterium tuberculosis Hsp10, either synthetic or recombinant, but not other related heat shock proteins (GroES from Escherichia coli or bovine Ubiquitin), increases apoptosis in serum-deprived P19 mouse teratocarcinoma cells. The effect is dose-dependent, with a bell-shaped curve and peak activity at 10(-9) M (maximal effect: 62.9 +/- 17.7% increase, mean +/- SD, n = 10) and is specifically inhibited by a polyclonal antibody raised against the synthetic protein. On the other hand, when the same cells are exponentially growing, M. tuberculosis Hsp10 increases cell proliferation with a bell-shaped dose-response curve and a moderate decrease in potency (peak-activity at 10(-8)-10(-7) M, with a 43.7 +/- 8.1% increase, mean +/- SD, n = 3). Therefore, it appears that this bacterial protein can exert two opposite effects, behaving either as a death- or as a growth-promoting factor, depending on the conditions of the target.

Animals↗

Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone.

The neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) reduces fever and acute inflammation in the skin when administered centrally. The aim of the present research was to determine whether central alpha-MSH can also reduce signs of systemic inflammation in mice with endotoxemia. Increases in serum tumor necrosis factor-alpha and nitric oxide, induced by intraperitoneal administration of endotoxin, were modulated by central injection of a small concentration of alpha-MSH. Inducible nitric oxide synthase (iNOS) activity and iNOS mRNA in lungs and liver were likewise modulated by central alpha-MSH. Lung myeloperoxidase activity, a marker of neutrophil infiltration, was increased in endotoxemic mice; the increase was significantly less in lungs of mice treated with central alpha-MSH. Intraperitoneal administration of the small dose of alpha-MSH that was effective centrally did not alter any of the markers of inflammation. In experiments using immunoneutralization of central alpha-MSH, we tested the idea that endogenous peptide induced within the brain during systemic inflammation modulates host responses to endotoxic challenge in peripheral tissues. The data showed that proinflammatory agents induced by endotoxin in the circulation, lungs, and liver were significantly greater after blockade of central alpha-MSH. The results suggest that anti-inflammatory influences of neural origin that are triggered by alpha-MSH could be used to treat systemic inflammation.

Animals↗